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Background: Intracytoplasmic Sperm Injection (ICSI) is an Assisted Reproduction Technique (ART) which offers the
chance to conceive to patients presenting very low sperm counts (cryptozoospermia/severe oligozoospermia).
Sperm freezing before the oocyte pick-up, can prevent from a lack of spermatozoa on the day of the ICSI. It can
avoid the cancellation of the ICSI or the use of TESE (Testicular sperm extraction). The objective of this study was
to analyse the practice of sperm freezing for these patients in our center over 8 years and the rate of use of these
frozen sperms. We also compared the outcome of ICSIs with frozen versus ejaculated sperm.
Material and methods: We performed a retrospective epidemiological study between 2004 and 2011. We
recruited all the patients having a sperm count below 1 Million/mL and who were waiting for their first ICSI
attempt.
Results: 169 patients were recruited: 84 cryopreserved their sperm before the ICSI (secured ICSI) while 85 did not
(non-secured ICSI). Both groups were split in cryptozoospermia (<103 spermatozoa/ml): 19 and 17 patients
respectively, very severe oligozoospermia (103–105/ml): 37 and 13 patients, and severe oligozoospermia (105–106/
ml): 28 and 55 patients. The part of secured ICSI significantly increased from 29% during 2004–2007 to 74% during
2008–2011(p = 0.0029) and the frozen sperm was used in 5.9% of the cases. Median age was significantly higher
in the non secured ICSI group (33.57 vs 35.52 for men, p = 0.0069 and 30.45 vs 32.26 for women, p = 0.025) but
no significant difference was found in the outcome of the ICSI between frozen-thawed sperm and fresh
ejaculated sperm.
Conclusion: Sperm freezing before ICSI for severe oligozoospermic and cryptozoospermic patients significantly
increased in our practice but the rate of use remain very low. This encourages to define more accurate criteria
leading to sperm freezing.
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Contexte: L’ICSI (Intracytoplasmic Sperm Injection) permet aux patients porteurs d’une oligozoospermie sévère ou
d’une cryptozoospermie d’espérer concevoir un enfant. Ces patients courent parfois le risque de survenue d’une
azoospermie constatée le jour de l’ICSI. L’organisation préalable d’une ou plusieurs congélations spermatiques peut
permettre de prévenir ce risque. L’objectif de cette étude était d’évaluer cette pratique de congélation spermatique
de sécurité sur une période prolongée dans notre centre et d’évaluer le taux d’utilisation de ces spermes congelés
et les chances de grossesse au cours des ICSI, qu’elles soient faites avec les spermatozoïdes frais ou congelés et
selon la gravité de l’oligozoospermie.
Materiel et methodes: Il s’agit d’une étude rétrospective monocentrique descriptive de 2004 à 2011. Les critères
d’inclusion étaient une numération spermatique inférieure à 1 Million/mL pour une première tentative d’ICSI.
Resultats: 169 patients ont été recrutés: 84 ont bénéficié de congélation de spermatozoïdes avant l’ICSI (ICSI
sécurisée) et 85 patients n’en ont pas bénéficié (ICSI non sécurisée). Au sein de ces deux groupes, les patients
ont été répartis en 3 sous-groupes en fonction de leur concentration spermatique: cryptozoospermie (<103
spermatozoïdes/ml), 19 et 17 patients, oligozoospermie très sévère (103–105/ml), 37 et 13 patients, et oligozoospermie
sévère (105–106/ml): 28 et 55 patients. Durant la période analysée nous avons observé une augmentation significative
du nombre de congélations spermatiques préalables à une ICSI, passant de 29% des tentatives pour 2004–2007 à 74%
des tentatives pour 2008–2011 (p = 0.0029. Seulement 5,9% des patients ont utilisé les spermatozoïdes congelés. L’âge
moyen des patients s’est avéré significativement plus élevé dans le groupe des ICSI sans congélation spermatique
que avec congélation spermatique (33.57 vs 35.52 chez les hommes, p = 0.0069 et 30.45 vs 32.26 chez les femmes,
p = 0.025) sans qu’il y ait de différence significative dans l’issue des tentatives d’ICSI.
Conclusion: La congélation spermatique avant ICSI dans le cas des oligozoospermies sévères et cryptozoospermies est
devenue presque systématique dans notre pratique. Pour autant l’utilisation de ces spermatozoïdes congelés demeure
très peu fréquente. Ceci nous engage à poursuivre l’étude de ces situations afin de définir des critères cliniques et/ou
biologiques justifiant ces congélations souvent itératives.
Mots cles: Cryptozoospermie, ICSI, Infertilité masculine, Oligozoospermie, Congélation spermatiqueBackground
Since the 90’s the Intracytoplasmic Sperm Injection (ICSI)
has considerably improved the Assisted Reproductive
Technologies [1]. This technique allows men with a very
low sperm count to achieve their project of parenthood.
Cryptozoospermic patients and non-obstructive azoosper-
mic patients can successfully undergo this technique be-
cause even these patients can produce extremely rare
sperms [2] leading to the notion of virtual azoospermia
[3]. In these cases, only very meticulous methods of sperm
searching in repeated semen samples allow to retrieve
these rare sperms [4-6].
ICSI remains difficult in this population of patients,
because we can face an absence or an insufficient num-
ber of spermatozoa in the semen on the day of the oo-
cyte pick-up. The ICSI may thus be cancelled. Several
centers have organized an alternative TESE (Testicular
or Epididymal Sperm Extraction) synchronous to oocyte
pick-up to prevent cancelling the ICSI in these cases.
Nowadays another option through oocyte vitrification
for further use (with a planified TESE or frozen ejacu-
lated sperm) may also be offered but it only postpones
the resolution of the lack of sperm.
In other centers, synchronous ICSI-TESE is not possible
and they have developed a politic of extended search inrepeated ejaculates according to Koscinski et al. [7] com-
bined to microfreezing before the ovarian stimulation has
started. This option of “security straw” freezing avoids not
only cancellation of the ICSI but also a premature TESE
[7,8]. Extended to the patients who have very low sperm
count, this micro-freezing of security straws can also pre-
vent further azoospermia of these patients. But is this
practice really useful for the patients and can it be man-
aged over long periods?
In order to evaluate this practice, we designed a retro-
spective study to address the following objectives:
– The main objective was to describe the evolution of
sperm banking over a long period and analyze the
rate of use of the banked sperm in the specific group
of patients carrying cryptozoospermia or severe
oligozoospermia
– The secondary objective was to compare the success
rates of the ICSIs done with fresh vs frozen sperm
when very few motile sperm is available.
Material and methods
Patients
We conducted a retrospective epidemiological study in the
IVF and CECOS center of Grenoble University Hospital.
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performed their first ICSI attempt between January 2004
and December 2011 were included in the study. The pa-
tients who had a sperm storage due to gonadotoxic treat-
ment were excluded from the study. We restricted the
study to the first ICSI attempts in order not to introduce a
bias of recruitment in the ICSI success rate analysis. The
study was ethically ruled through a non-opposition proced-
ure, since it did not contain any extra sampling procedure
or specific identified risk for the patients.
The data were extracted from a home-made Access®
IVF database for the years 2004 to 2009 and from the
Medifirst® system for the years 2009 to 2011. We also
consulted the paper records of our sperm bank to ensure
that we included all the patients who fitted the inclusion
criteria. Once the data had been extracted from the
paper or electronic files, we divided our data in two
groups of patients: patients having or not sperm storage
in the months preceding the first ICSI (respectively
named secured ICSI and non secured ICSI groups). For
each man, we collected, the date of birth, the date of the
ICSI and the sperm count at the day of the ICSI. The pa-
tients were split in three groups according to the severity
of the oligozoospermia: cryptozoospermia (spermatozoa
observed only in the pellet with sperm concentration
always <0.001 × 106/mL), very severe oligozoospermia
(sperms observed sparsely in a few fields at × 400 magnifi-
cation of the fresh preparation with sperm concentration
from 0.001 to 0.1 × 106 spermatozoa/mL) and severe oli-
gozoospermia (sperms observed sparsely in all the fields
at × 400 magnification in the fresh preparation with sperm
concentration from 0.1 to 1 × 106 spermatozoa/mL).
For all the ICSIs, we collected:
– the date of birth of the female partner and the date
of oocyte pick-up,
– the number of oocytes retrieved, metaphase two
oocytes injected and two-pronuclei zygotes obtained
(to determine the fertilization rate),
– the number of cleaved embryos on day 2
(to determine the cleavage rate),
– the number of transferred or frozen embryos,
– the number of ongoing clinical pregnancy
(developing embryo with cardiac activity at the
echography 1 month after the ICSI).
In the secured ICSI group, the date of the sperm
storage and the number of straws stored and/or thawed
were also compiled.
Sperm analysis and freezing procedure
Sperm analysis was performed according to the WHO
recommendations: WHO 1999 [9]. Before freezing, the
semen was diluted (v/v: 1/0.7) at room temperature withSpermFreeze® (FertiPro, Beernem, Belgium) with mild
and continuous shaking. In order to increase the sperm
concentration, the sample was frequently centrifuged
(10 min at 200G) before adding the freezing medium.
The mix was then loaded in 0.3 mL straws. Samples were
cooled from room temperature to -150°C following an au-
tomated (Planer Kryo 560®, CryoBioSystem) 3 slopes cool-
ing procedure (from room temperature to -8°C at -5°C/
min, from -8°C to -25°C at -10°C/min and from -25°C
to -150°C at -20°C/min). When -150°C was reached, the
straws were immediately plunged and stored in liquid
nitrogen.
In vitro fertilization by ICSI
The ovarian stimulations, the oocyte retrieval and the
ICSI procedure were conducted according to the stan-
dardized protocols as previously described [10,11]. The
semen was collected by masturbation on the day of the
ICSI and prepared using discontinuous three layers dens-
ity gradient (PureSperm 100® Nidacon/Sperm Preparation
Medium® Origio, v/v): 1 mL 1/0, 1 mL 0.7/0.3 and 1.5 mL
0.4/0.6). In case of cryptozoospermia or a sperm motility
below 20%, the layers were 0.4 mL of 1/0, 0.4 mL 0.7/0.3
and 0.6 mL of 0.4/0.6. If no spermatozoon was observed
in the first 10 μL of the ejaculate, a two layers density gra-
dient centrifugation (0.4 mL of 1/0 and 0.6 mL of 0.4/0.6)
or a simple centrifugation (10 min, 200G) was realized
and, if there still was no spermatozoon observed, a second
retrieval was proposed. After two unsuccessful samples,
one or more straws were thawed.
Oocytes were retrieved in Flushing Medium® (Origio)
at day 0 and moved in IVF® Medium (Origio). Then, the
cumulus-corona cells were removed by exposure to hyal-
uronidase (JCD® 80UI/mL) diluted (v/v 1/1) with IVF®
medium (Origio). Each metaphase II oocyte was dis-
posed in a drop of Sperm Preparation Medium® (Origio),
the prepared sperm were put in a drop of PVP® (Origio)
and the ICSI was performed under inverted microscopic
control (Axiovert 35 M®, Zeiss or IX81® Olympus). After
the injection, the oocytes were placed in ISM1® medium
(Origio) and incubated at 37°C (5% CO2, cytoperm 2®,
Thermo Scientific Heraeus).
Appearance of 2 pronuclei was noted at day 1 and the
embryo cleavage was quoted at day 2 and further. The
embryos were transferred between day 2 and day 5. If
possible, embryos were moved in BlastAssist® (Origio) at
day 3 to achieve blastocyst stage. Supernumerary em-
bryos were frozen either at day 2, 3 or 5.
Statistical analysis
R 3.0.2 or Excel 2013 software was used for statistical
analysis. χ2 test was used for qualitative variables and
Student’s test was applied for quantitative variables with
a significance level at 5% for both tests.
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Description of the analyzed population
169 couples who had their first ICSI attempt between
2004 and 2011, with a sperm count of one million/mL
or less were included in the study. ICSI without any
sperm freezing (non secured ICSI) was performed for 84
couples, while the other 85 men had at least one sperm
sample frozen before the first ICSI attempt (secured
ICSI). The general and seminal characteristics of each
group are described in Table 1. The men who cryopre-
served their sperm before ICSI were significantly youn-
ger (mean age was 33.57 in secured ICSI group vs 35.52
for the non secured ICSI group, p < 0.05). The partners in
the first group were also younger with approximately the
same difference in age (30.45 years vs 32.26, p < 0.01).
Mean sperm count in the secured ICSI group was sig-
nificantly lower than in the non secured ICSI group
(0.192 × 106/mL versus 0.399 × 106/mL, p < 0.001). The
part of the cryptozoospermic patients was not different
among both groups (22.6% vs 20.0%, p = NS); while the
secured ICSI group contained mainly very severe oligo-
zoospermia (44.0% vs 15.3%, p < 0.001) and the non se-
cured ICSI group mainly non severe oligozoospermia
(64.7% vs 33.3, p < 0.001). Mean sperm count for severe
oligozoospermia or cryptozoospermia was not different
in both groups (0.564 × 106/mL vs 0.616 × 106/mL, p =
NS for severe oligozoospermia and 0.0003 × 106/mL vs
0.0002 × 106/mL, p = NS for cryptozoospermia), while
the mean sperm count among very severe oligozoosper-
mia was significantly lower in the non secured-ICSI
group than in the secured-ICSI group (0.0030 × 106/mL
vs 0.0095 × 106/mL, p < 0.05).
The practice of sperm banking over the analyzed period
We secondly analyzed the data of sperm freezing and
banking over the period (Table 2). Considering the whole
population, an average of 2.23 sperm samples was frozenTable 1 General characteristics and sperm parameters of the
Secured ICSI group
Mean Median
Female age (year) 30.45 30.50
Male age (year) 33.57 33,00
Sperm count (×106/mL) 0.192 0.006
Cryptozoospermia number of patients 19/84 (22.6%
Sperm count (×106/mL) 0.0003 0.0002
Very Severe oligozoospermia number of patients 37/84 (44.0%
Sperm count (×106/mL) 0.0095 0.0040
Severe oligozoospermia number of patients 28/84 (33.3%
Sperm count (×106/mL) 0.564 0.600
Secured ICSI: ICSI with previously frozen sperm; non secured ICSI: ICSI without prev
*Significant p values at 5%, **Significant p value at 1%, ***Significant p value at 0.1for each patient. The mean number of straws was of
10.04. When analyzing these data among the different
subgroups, we observed that the mean number of samples
was lower in case of severe oligozoospermia, while the
lowest number of straws was observed in the cryptozoos-
permia group. The mean number of samples was not very
different when considering each subgroup of patients
(respectively 2.73 for cryptozoospermia; 2.46 in case of
very severe oligozoospermia and 1.57 for severe oligo-
zoospermia) but 75% of the severe oligozoospermic
patients performed only one sample, while 75% of the
cryptozoospermic ones came two to 5 times in the lab
for sperm freezing. We also noticed that the patients
with very severe or severe oligozoospermia had at least
4 straws in our tanks while several of the cryptozoosper-
mic patients had only one straw. Analysis of the distri-
bution of the number of straw according to the number
of frozen samples among the different subgroups (Figure 1)
revealed that the patients having the lowest amount of fro-
zen straws were those for whom only one sample could be
frozen, often despite several venues in the lab.
We looked further at the distribution of secured and
non secured ICSIs along the time between 2004 and
2011 (Figure 2). The global analysis over the whole period
clearly showed an increase of sperm freezing in case of se-
vere oligozoospermia as illustrated by the increase of se-
cured ICSI over the time (Figure 2 left). In 2004, none of
the patient had his sperm frozen before an ICSI. Between
2005 and 2010, the rate of secured ICSIs for oligozoosper-
mia raised from 30% to 95% and in 2011, only one oligo-
zoospermic man underwent an ICSI in our center without
any previous frozen sperm. We divided the 8 years period
in two equal periods of 4 years and observed a signifi-
cant difference in the percentage of secured ICSIs be-
tween the two periods 2004–2007 and 2008–2011 (29%
vs 74% of secured ICSI for oligozoospermia, p < 0.001,
Figure 2 right).analyzed population
(n = 84) Non secured ICSI group (n = 85) p-value
min-max Mean Median min-max
21–40 32.26 32.00 22–42 0.0069**
23–56 35.52 35.00 22–49 0.0254*
0–1 0.399 0.200 0–1 0.000263***
) 17/85 (20.0%) 0.819
0–0.0009 0.0002 0.0001 0–0.0009 0.187
) 13/85 (15.3%) 0.0000863***
0.001–0.006 0.0030 0.0020 0.001–0.007 0.0177*
) 55/85 (64.7%) 0.0000867***
0.1–1 0.616 0.800 0.1–1 0.494
iously frozen sperm.
%.
Table 2 Characteristics of sperm cryopreservations
Colonne1 Mean min-max 1st quartile median 3rd quartile Patients
Frozen samples per patient 2.23 1–5 1 2 3 All the patients with sperm storage (n = 84)
2.73 1–5 1 2 4 Cryptozoospermic patients (n = 19)
2.46 1–5 2 2 3 Very severe oligozoospermic patients (n = 37)
1.57 1–4 1 1 2 Severe oligozoospermic patients (n = 28)
No of straws per patient 10.04 1–26 7 10 12,25 All the patients with sperm storage (n = 84)
7.53 1–15 4 7 10.5 Cryptozoospermic patients (n = 19)
10.92 4–22 8 10 13 Very severe oligozoospermic patients (n = 37)
10.57 4–26 7.75 9.5 12.25 Severe oligozoospermic patients (n = 28)
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Among the 84 couple who had frozen sperm before the
ICSI, thawing sperm was necessary for only 5 patients,
which corresponded to 5.9% of use of the frozen sperm
(Table 3). The reasons leading to thaw straws were: ab-
sence or insufficient number of spermatozoa in the fresh
ejaculate (after two sperm sampling) on the day of the
ICSI attempt (4 patients) or remaining bacteria in sperm
before the attempt, despite repeated and adapted antibi-
otics (1 patient). Sperm samples were thawed among the
three categories of oligozoospermic patients but the
highest rate of use was observed among the cryptozoos-
permic groups (10.5%).
Do the patients have the same chances of pregnancy as
the sperm parameters decrease?
We compared the ICSI attempts in the three groups of
men (Table 4) and found a significantly higher embryo
cleavage rate in case of severe oligozoospermia compared
to very severe oligozoospermia or cryptozoospermia (76%
vs 64%, p = 0.02 and 76% vs 66%, p = 0.02 respectively).
We also noticed a significantly higher number of frozen


















Figure 1 Distribution of the number of straws according to the numbsevere oligozoospermia (2.12 versus 0.86, p = 0.00031).
But analysing the implantation rates revealed no signifi-
cant difference among the groups, neither was observed a
difference in fertilization rate, number of embryo trans-
ferred, pregnancy rate or birth rate per ICSI cycle.
Success rate of the ICSIs using fresh or frozen sperm
We compared the results of ICSI (Table 5) with fresh ejac-
ulated sperm (group A) or thawed sperm (group B). Since
there was no difference between secured and non secured
ICSI with fresh ejaculated sperm (data not shown), the
results of these two groups were pooled in group A. The
analysis revealed no difference for all the data analyzed
(age of the patients, number of oocytes collected or
injected, fertilization rate, and cleavage rate, number of
transferred or frozen embryos, pregnancy rate, implant-
ation rate and birth rate).
Discussion
What about routine sperm storage in case of
oligozoospermia?
Routine use of sperm storage started in the 60’s for pa-





er of frozen samples in the three subgroups of patients.
Figure 2 Evolution of the distribution of secured and non-secured ICSIs between 2004 and 2011. Left: Evolution between 2004 and 2011.
Right: Comparison between the period 2004–2007 and 2008–2011.
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tients presenting a very low sperm count or suspected at
high risk of rapid decrease in the sperm count (possibly
linked to several genetic origins of the oligozoospermia)
and asking for Assisted Reproductive Techniques [13].
This practice was also reinforced in our center by several
cases of severe male infertility which led to azoospermia
even before the first ICSI had been done. Nevertheless,
it is a time consuming practice and only few studies
were available so far to evaluate the real benefit for the
patients. The first important one was by Lahav-Baratz et
al and described the interest of sperm pooling and cryo-
preservation before the ICSI [8].
When comparing our sperm storage data to the litera-
ture, we see that the amount of samples per patient is
not different from those observed in case of sperm stor-
age before gonadotoxic treatment [14-16], but the num-
ber of straws is lower. In case of cancer, most of the
patients show normal or subnormal sperm count. It is
thus not necessary to concentrate the sperm cells before
freezing, this allows to make more straws than in the
case of severe oligozoospermia or cryptozoospermia.
The analysis of the evolution of the sperm storage dur-
ing ART in our center shows a rising proposal of cryo-
preservation before ICSI for severe oligozoospermia.
Between 2004 and 2011, the percentage of patients who
were offered the opportunity of sperm storage, to preventTable 3 Rate of use of the frozen sperm among the
secured ICSI population
Number of patients whose frozen
sperm was thawed to perform
the ICSI (rate of use)
All the patients 5/84 (5.9%)
Cryptozoospermia 2/19 (10.5%)
Very severe oligozoospermia 1/37 (2.7%)
Severe oligozoospermia 2/28 (7.1%)future azoospermia during the ICSI protocols, increased
from 30% to 95%. A significant difference of age is ob-
served among our patients according to sperm banking
before ICSI or not. The first group is 1.5 year younger for
men and 2 years younger for their female partner. It is sur-
prising because we may be more prone to propose sperm
banking to older men to prevent further decrease, while
our analysis reveals the opposite. A possible explanation
may be that the high degree of oligozoospermia leads to a
faster ICSI proposal to these couples. Ping and collabora-
tors analyzed the practice of sperm storage and reuse in
China between 2003 and 2008 [17]. The main part of their
indication for sperm banking was the risk of sperm collec-
tion failure or couple separation on the day of the ICSI,
while oligozoospermia represented 4.8% of ART patients
with sperm banking (66/1374). The mean sperm count for
their oligozoospermic patients was 3.1 × 106.
It is noticeable that we observed a significantly higher
proportion of very severe oligozoospermic patients and a
lower rate of severe oligozoospermic patients in the se-
cured ICSI group. It is not surprising because we were
more prone to suggest a cryopreservation for lower sperm
count but, interestingly, we did not find any significant dif-
ference for cryptozoospermic patients. The mean sperm
count was also higher in the secured ICSI group compared
to the non secured ICSI group for the whole panel of pa-
tients. It could be explained by the decreasing trend in the
mean sperm count along the time of the study (Additional
file 1: Figure S1) considering the fact that most of the se-
cured ICSI were realized in the second part of the study.
Are the frozen straws frequently used by the
oligozoospermic patients?
Few of our patients used their frozen sperm on the day
of ICSI, resulting in a 5.9% rate of use. Most of the stud-
ies available in the literature concerning the rate of fro-
zen sperm use concern sperm banking before cancer
therapies [14,15,18]. The rates observed vary from 2.7 to
Table 4 ICSI outcome according to the severity of the oligozoospermia
Cryptozoospermia
(group 1) n = 36
Very severe
oligozoospermia
(group 2) n = 50
Severe
oligozoospermia










Mean (total) IC 95% Mean (total) IC 95% Mean (total) IC 95%
Women’s age (years) 31.7 ± 1.51 30.8 ± 1.13 31.6 ± 0.96 0.4 0.89 0.30
Men’s age (years) 34.0 ± 1.75 34.7 ± 1.71 34.7 ± 1.19 0.59 0.54 0.99
Sperm count (106/mL) 0.00028 ± 0.000092 0.0078 ± 0.0037 0.60 ± 0.070 0.00026* 2.5 × 10 -28* 5.2*10 -28*
Use of thawed sperm 2/36 (5.5%) 1/50 (2.0%) 2/83 (2.4%) 0.57 0.58 1
No of oocytes retrieved 10.17 (366) ± 1.95 11.30 (554) ± 2.33 10.51 (862) ± 1.27 0.47 0.77 0.56
No of oocytes injected 8.17 (294) ± 1.85 9.14 (448) ± 1.44 8.71 (723) ± 1.07 0.42 0.62 0.64
Fertilization rate 0.56 (165) ± 0.07 0.56 (236) ± 0.07 0.64 (455) ± 0.05 0.94 0.10 0.08
Cleavage rate 0.64 (200) ± 0.08 0.66 (283) ± 0.06 0.76 (541) ± 0.04 0.71 0.02* 0.02*
No of transferred embryos 1.31 (47) ± 0.22 1.40 (70) ± 0.16 1.37 (114) ± 0.14 0.49 0.61 0.80
No of frozen embryos 1.33 (48) ± 0.70 0.86 (43) ± 0.34 2.12 (176) ± 0.57 0.24 0.09 0.00031*
Pregnancy rate per ICSI cycle 0.19 (7) ± 0.13 0.32 (16) ± 0.13 0.23 (19) ± 0.09 0.19 0.68 0.25
Implantation rate 0.20 ± 0.14 0.24 ± 0.03 0.19 ± 0.09 0.68 0.90 0.49
Birth rate per ICSI cycle 0.14 (5) ± 0.11 0.18 (9) ± 0.11 0.23 (19) ± 0.09 0.61 0.26 0.50
*Significant p values below 5%. (Student’s t test).
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by Koscinski et al. among severe oligozoospermic pa-
tients, our results are in accordance (5.9% in our study
vs 5.6% in their study). They observed a higher rate of
use in case of cryptozoospermia when compared to very
severe or severe oligozoosermia (our number of attempt
is too small to allow a robust comparison of this point).
The rate of thawing sperm for ICSI in case of oligozoos-
permia is even lower in the study by Ping et al. (3.0%,
2/66) [17] but no information is available in their study
concerning the distribution of their patients according
to the severity of the oligozoospermia. Moreover, since
sperm banking is not costless in China, there is certainlyTable 5 Analysis of the ICSIs with ejaculated sperm or thawed
ICSIs with fresh sperm (group A)
Mean (total) IC 95%
Women’s age (years) 31.4 ±0.68
Men’age (years) 34.6 ±0.88
Sperm count (/ml) 298 × 103 ±58 × 103
No of oocytes retrieved 10.68 (1741) ±1.03
No of oocytes injected 8.70 (1418) ±0.79
Fertilization rate 0.60 (833) ±0.04
Cleavage rate 0.70 (995) ±0.04
No of embryos transferred 1.37 (225) ±0.10
Number of frozen embryos 1.57 (257) ±0.35
Pregnancy rate per ICSI cycle 0.25 (41) ±0.07
Implantation rate 0.21 0.06
Birth rate per ICSI cycle 0.20 (32) ±0.06
No significant difference for all parameters. (Student’s t test).a major bias of inclusion in their study The difference in
rate of use between cancer situations and oligozoosper-
mic situations may be explained by a higher risk of
azoospermia in case of gonadotoxic treatment combined
with a longer period of analysis in case of sperm banking
before cancer treatment. We were not able to follow the
evolution of this rate because of the shortness of our
study and the low rate of use. This rate of use also high-
lights the need to better determine clinical and/or bio-
logical recommendations for sperm banking in case of
severe oligozoospermia. We have defined our limit for
such proposal, below 1Million/mL for the sperm count
and within this limit, the rates of use are not higher insperm
ICSIs with thawed sperm (group B) p-value
Mean (total) IC 95%
29.8 ±1.80 0.159
33.4 ±3.75 0.576
242 × 103 ±280 × 103 0.717
10.25 (52) ±6.73 0.918
9.4 (47) ±5.7 0.823
0.57 (23) ±0.13 0.715
0.77 (29) ±0.23 0.628
1.20 (6) ±0.45 0.446
2.00 (10) ±1.75 0.658
0.20 (1) ±0.39 0.642
0.20 ±0.35 0.962
0.20 (1) ±0.35 0.862
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mia group. It should be useful to consider other parame-
ters such as couple’s age, pathologies and sterilizing factors,
and/or the hormonal status (FSH, LH, testosterone, inhi-
bine B) of the men to decide if sperm banking has to be
proposed and not focus only on the sperm count. A pro-
spective study including all the previously mentioned pa-
rameters may be of relevance to address this point.
Do the patients have the same chances of pregnancy
even when sperm parameters are very low?
The results of ICSI for the whole cohort of patients are
similar to those in the literature [7]. When we compare
the results according to the sperm count, we find signifi-
cant differences in the cleavage rate and the number of
frozen embryos while no difference is observed in age,
neither for women nor for men. It is not surprising that
oligozoospermic patients have better outcomes than
cryptozoospermic ones, this has already been described:
Strassburger et al. [19] found significant decrease for the
number of 24 h-4 cells embryos and the number of fro-
zen embryos in case of very low sperm count. They also
observed a significant decrease in the pregnancy rate, but
only for cryptozoospermia group. We do not observe such
difference for pregnancy and birth rate between the three
groups. No significant difference in the ICSI outcome was
found between frozen sperm and fresh ejaculated sperm.
Although, the straws were used in a very few cases, others
observed the same results with ejaculated or surgically re-
trieved spermatozoa [20-22].
Repeated ejaculated sperm freezing or TESE?
When no spermatozoon is found the day of a non-secured
ICSI, several choices appear: the patient can undergo a
TESE (Testicular or Epididymal Sperm Extraction) if it
has been planned on the same day and if TESE is not pos-
sible, the oocytes have to be vitrified [23,24]. The question
will then concern the possible use of these oocytes either
through a planned TESE protocol or through a secured
ICSI. The very low rate of use of the frozen ejaculated
spermatozoa demonstrates a low risk of azoospermia on
the day of ICSI in balance with high time consuming pro-
cedure of repeated sperm freezing. Moreover, the chances
of pregnancy appear to be the same if ICSI is done with
fresh or frozen sperm even when the spermatozoa come
from the testis. We thus can wonder whether systematic-
ally planned TESE in case of cryptozoospermia or very se-
vere oligozoospermia should be preferred to the repeated
sperm freezing procedure. The fertilization or pregnancy
rates of TESE-ICSI are similar to ICSI with ejaculated
sperm [25-28] but TESE is at risk of testicular hematoma,
hematocele, infection or further hypogonadism [29-32].
Moreover, the question about the risk for the descendants
is still opened, because of the higher rate of aneuploidy[33,34] or abnormal epigenetic content of these spermato-
zoa [35,36]. Most of the studies report around 50% success
of sperm retrieval [37-43]. TESE can be repeated to in-
crease the chances to retrieve sperm [44] but the clinical
risks mentioned above remain. Thus if possible ejaculated
sperm freezing still remains simpler. To better evaluate
the real risk of azoospermia in case of cryptozoospermia
or severe oligozoospermia, multicenter prospective sur-
veys should be done.
Conclusion
Cryopreservation in case of severe oligozoospermia and
cryptozoospermia is a practice more and more often of-
fered to these patients. It allows avoiding the cancellation
of the ICSI or the planning of a synchronous TESE; In our
hands and considering the low frequency use of the thawed
sperm, the chances of pregnancy and birth appear the
same with fresh ejaculated or frozen-thawed sperm. The
rate of use of the frozen sperm being quite low, we prob-
ably need to better characterize the patients who are really
at risk of sperm decrease in order to avoid useless freezing.
We also need to plan long term prospective studies to
evaluate the real risk of azoospermia for these patients.
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